Search

Search Constraints

You searched for: Author/Creator Prochazka, V.

Search Results

2. Beyond rituximab maintenance. relapsing follicular lymphoma during or after end of rituximab maintenance: analysis of Czech Lymphoma Study Group (CLSG) database. (June 2017)

3. Cardiac lymphomas: Incidence and outcome in newly diagnosed non‐Hodgkin's lymphomas. Analysis from the Czech lymphoma study group (CLSG) database. (June 2017)

4. DOWN‐REGULATION OF MIR‐150 AND UP‐REGULATION OF ITS TARGET FOXP1 IS ASSOCIATED WITH TRANSFORMATION OF FOLLICULAR LYMPHOMA. (June 2017)

5. Effective Assessment of Diabetes Control Using Personal Glucometers (CONTOURLINK, Bayer, Germany; CALLA, Wellion, Austria; LINUS, Agamatrix, USA). Issue 6 (19th December 2013)

6. EXTRANODAL NATURAL KILLER (NK)/T‐CELL LYMPHOMA, NASAL TYPE – CASE REPORT AND REVIEW OF CZECH LYMPHOMA STUDY GROUP (CLSG) DATABASE. (12th June 2019)

7. INCIDENCE AND OUTCOME OF PRIMARY EXTRANODAL FOLLICULAR LYMPHOMAS. ANALYSIS FROM THE CZECH LYMPHOMA STUDY GROUP (CLSG) REGISTRY. (June 2017)

8. IS IT RADIOTHERAPY NECESSARY FOR PRIMARY MEDIASTINAL B‐CELL LYMPHOMA (PMBL) PATIENTS ACHIEVING PET NEGATIVITY AFTER IMMUNOCHEMOTHERAPY?. (12th June 2019)

9. MAINTENANCE RITUXIMAB IMPROVES SURVIVAL IN NEWLY DIAGNOSED MANTLE CELL LYMPHOMA PATIENTS: ANALYSIS OF THE CZECH LYMPHOMA STUDY GROUP. (June 2017)